Acticlate FDA Approval History
Acticlate (doxycycline hyclate) is a tetracycline-class antibacterial indicated for the treatment of a number of infections, including adjunctive therapy in severe acne.
Development Timeline for Acticlate
|Jul 28, 2014||Approval Aqua Pharmaceuticals Announces FDA Approval of Acticlate (doxycycline hyclate USP) Tablets|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.